Heidbreder Christian sold $707K of INDV
Heidbreder Christian (Chief Scientific Officer) sold 18,586 shares of Indivior Pharmaceuticals, Inc. (INDV) at $38.06 ($0.71M total) on 2026-06-11 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a fresh, primary-source datapoint on insider activity, but it does not include new operational, clinical, regulatory, or financial guidance.
Market read
Useful for monitoring insider behavior, but unlikely to drive a fundamental repricing without accompanying company-specific catalysts.
What to watch
Traders may focus on the sale size, but the key nuance is the 10b5-1 structure and the post-transaction holdings (227,923 shares), which can indicate continued long-term exposure.
Background
The article is an SEC EDGAR Form 4 insider transaction for Indivior Pharmaceuticals, Inc.
Ticker impact
Indivior CSO Christian Heidbreder sold 18,586 shares (~$707K) via an open-market transaction under a pre-arranged 10b5-1 plan.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
The filing is a Form 4 insider sale with a stated 10b5-1 pre-arranged plan, which typically reduces interpretive signal versus discretionary selling.
Market effects
No direct sector read-through; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, the market may overreact; the disclosure could be largely mechanical rather than a bearish signal.
Key entities
- issuerIndivior Pharmaceuticals, Inc.
Company whose insider transaction was reported on SEC Form 4.
- insiderChristian Heidbreder
Chief Scientific Officer who sold shares under a 10b5-1 plan.
